HFPEF - HEART FAILURE WITH PRESERVED EJECTION FRACTION
Clinical trials for HFPEF - HEART FAILURE WITH PRESERVED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HFPEF - HEART FAILURE WITH PRESERVED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HFPEF - HEART FAILURE WITH PRESERVED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Exercise as medicine: can a tailored workout program reduce hospital visits for heart failure patients?
Disease control Not yet recruitingThis trial tests whether a year-long, supervised exercise program — including aerobic, resistance, and breathing exercises — can improve outcomes for people with heart failure with preserved ejection fraction (HFpEF). Participants are randomly assigned to either usual care or usu…
Matched conditions: HFPEF - HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase: NA • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Tailored HIIT may boost fitness in stubborn heart failure
Disease control Not yet recruitingThis study tests whether a personalized high-intensity interval training (HIIT) program can improve exercise capacity and quality of life in people with heart failure with preserved ejection fraction (HFpEF). Participants are randomly assigned to either a 24-week HIIT plan tailor…
Matched conditions: HFPEF - HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New hope for heart patients: drug may cut death risk after valve surgery
Disease control Not yet recruitingThis study tests whether the drug finerenone can help people with heart failure who have had a heart valve replacement (TAVI). About 2,800 older adults will be randomly assigned to receive finerenone or a placebo. The goal is to see if the drug lowers the chance of death or worse…
Matched conditions: HFPEF - HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC